Pharmaleads SA
http://www.pharmaleads.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Pharmaleads SA
Merck KGaA's M Ventures Moving On Up With €600m Boost
The new capital will allow the VC arm to create and finance "a new and larger portfolio of innovative companies that align with the future strategies" of Merck's businesses.
China Foreign Brand Boycott To Spill To Health Sector?
Amid a rising tide of sentiment against foreign consumer brands in China, observers say the impact could be far-reaching. But other factors may be more important than public opinion, and innovation will remain a key to success for health sector players.
Pharmaleads CEO Outlines Pipeline Of Non-Opiate Pain Therapies
On the sidelines of the 2017 BIO-Europe partnering meeting, Scrip talks to Thierry Bourbié, chair and CEO of Pharmaleads, a pharmaceutical company developing non-opiate products for the management of acute and chronic severe pain.
Deals Shaping the Medical Industry (01/2009)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
-
Drug Discovery Tools
- ADMET
- Other Names / Subsidiaries
-
- Pharmaleads SAS
- Pharmaleads Greater China
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice